In conclusion, using the SMO antagonists GDC-0449 and cyclopamine, no correlation between growth inhibition and reduction of GLI1 mRNA levels could be detected in the four tumor cell lines PANC-1, SUIT-2, PC-3 and FEMX. This evidence concerns the gene GLI1 and neoplasm.